Clinical Study
Effects of Obstructive Sleep Apnea on Cardiac Function and Clinical Outcomes in Chinese Patients with ST-Elevation Myocardial Infarction
Table 1
Baseline characteristics of enrolled patients.
| | Characteristic | OSA group () | Non-OSA group () | value | | Number | (%) | Number | (%) |
| | Age (mean ± SD) | 61.45 ± 7.30 | | 61.57 ± 7.25 | | 0.912 | | Gender | | | | | 0.362 | | Male | 61 | (68.5) | 71 | (65.1) | | | Female | 28 | (31.5) | 38 | (34.9) | | | Hypertension | | | | | 0.122 | | Yes | 54 | (60.7) | 56 | (51.4) | | | No | 35 | (39.3) | 53 | (48.6) | | | Diabetes mellitus | | | | | 0.413 | | Yes | 25 | (28.1) | 28 | (25.7) | | | No | 64 | (71.9) | 81 | (74.3) | | | Lipid disorders | | | | | 0.052 | | Yes | 15 | (16.9) | 9 | (8.3) | | | No | 74 | (83.1) | 100 | (91.7) | | | CKD | | | | | 0.495 | | Yes | 8 | (9.0) | 11 | (10.1) | | | No | 81 | (91.0) | 98 | (89.9) | | | Tobacco use | | | | | 0.378 | | Yes | 23 | (25.8) | 25 | (22.9) | | | No | 66 | (74.2) | 84 | (77.1) | | | Drinking habit | | | | | 0.480 | | Yes | 15 | (16.9) | 17 | (15.6) | | | No | 74 | (83.1) | 92 | (84.4) | | | Prior PCI | | | | | 0.698 | | Yes | 1 | (1.1) | 1 | (0.9) | | | No | 88 | (98.9) | 108 | (99.1) | | | Prior CABG | | | | | 0.039 | | Yes | 4 | (4.5) | 0 | (0) | | | No | 85 | (95.5) | 109 | (100) | | | cTnT | 4.58 ± 3.66 | | 4.72 ± 3.82 | | 0.794 | | DAPT adherence | | | | | 0.173 | | Yes | 76 | (85.4) | 99 | (90.8) | | | No | 13 | (14.6) | 10 | (9.2) | | | Socioeconomic status | | | | | 0.048 | | Low | 9 | | 18 | | | | Medium | 68 | | 50 | | | | High | 32 | | 21 | | | | Abdominal circumference (mean ± SD) | 90.0 ± 9.4 | | 87.4 ± 8.9 | | 0.046 | | BMI (mean ± SD) | 28.8 ± 4.5 | | 24.6 ± 3.1 | | < 0.001 | | Aspirin | | | | | 0.334 | | Yes | 81 | (91.0) | 96 | (88.1) | | | No | 8 | (9.0) | 13 | (11.9) | | | Clopidogrel | | | | | 0.283 | | Yes | 83 | (93.3) | 98 | (89.9) | | | No | 6 | (6.7) | 11 | (10.1) | | | ACEI/ARB | | | | | 0.523 | | Yes | 46 | (51.7) | 57 | (52.3) | | | No | 43 | (48.3) | 52 | (47.7) | | | β-blockers | | | | | 0.478 | | Yes | 51 | (57.3) | 64 | (58.7) | | | No | 38 | (42.7) | 45 |
(41.3) | | | Statins | | | | | 0.378 | | Yes | 79 | (88.8) | 94 | (86.2) | | | No | 10 | (11.2) | 15 | (13.8) | | | Nitrates | | | | | 0.069 | | Yes | 36 | (40.4) | 32 | (29.4) | | | No | 53 | (59.6) | 77 | (70.6) | | | CCB | | | | | 0.589 | | Yes | 9 | (10.9) | 11 | (10.1) | | | No | 80 | (88.1) | 98 | (89.9) | | | Diuretics | | | | | 0.159 | | Yes | 6 | (6.7) | 3 | (2.8) | | | No | 83 | (93.3) | 106 | (97.2) | | | Digitalis | | | | | 0.375 | | Yes | 5 | (5.6) | 4 | (3.7) | | | No | 84 | (94.4) | 105 | (96.3) | |
|
|
CKD: chronic kidney disease; PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; cTnT: cardiac troponin T; DAPT: dual antiplatelet therapy; BMI: body mass index; ACEI: angiotesin converting enzyme inhibitors; ARB: angiotensin II receptor blockers; CCB: calcium channel blockers.
|
